LEARNER RECORDS: EVALUATION You must complete the program evaluation and applicable activity evaluation(s) in order to earn AMA PRA Category 1 Credits TM , MOC points, or participation in MIPS. For each of the objectives determine if the activity increased your: A Competence B Performance C Outcome D No Change
SUBSTANCE USE DISORDERS: A DEA REQUIREMENT
A B C D
1. Discuss substance use disorders . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
2. Describe the roles of the U.S. Drug Enforcement Agency (DEA), Food and Drug Administration (FDA), and Department of Health and Human Services (HHS) in scheduling controlled substances and enforcing controlled substance laws and regulations. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
3. Understand the different DEA Controlled Substance Schedules and prescribing regulations associated with the different DEA Controlled Substance Schedules. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
4. Review medical marijuana legislation. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
5. Describe essential considerations when prescribing controlled substances, including regulatory exceptions and clinical concerns. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
6. Describe controlled substance prescribing practices.. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
7. Understand the treatment options for patients suffering from substance use disorder (SUD). . . . . . . . . . . . .
8. Please identify a specific change, if any, you will make in your practice related to substance use disorders.
9. What do you see as a barrier to making these changes?
OVERALL PROGRAM:
Yes No If no, please explain:
10. The program was balanced, objective and scientifically valid . . . . . . . . . . . . . .
11. Do you feel the program was scientifically sound and free of commercial bias or influence?
12. How can this program be improved?
13. Based on your educational needs, please provide us with suggestions for future program topics and formats.
14. Would you like to use this activity participation as a clinical practice improvement activity (CPIA) for MIPS? Yes No
49
Powered by FlippingBook